# Equity Bancshares Inc: overview

EQBK · NYSE · CIK 1227500 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/eqbk.md) · [Financials](/companies/eqbk/financials.md) · [Filings](/companies/eqbk/filings.md) · [Insiders](/companies/eqbk/insiders.md)

Revenue is not reported in this company’s XBRL financial statements.

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Diluted EPS | $ per share | [1.28](/filings/0001193125-25-262699.md) | not reported | [0.85](/filings/0001193125-26-214751.md) | [0.86](/filings/0001193125-26-340292.md) | [(1.55)](/filings/0001193125-25-262699.md) | not reported | [0.80](/filings/0001193125-26-214751.md) | [1.27](/filings/0001193125-26-340292.md) |
| Free cash flow | $m | [19.7 d](/filings/0001193125-25-262699.md) | [19.9 d](/filings/0001193125-26-100184.md) | [20.2](/filings/0001193125-26-214751.md) | [26.0 d](/filings/0001193125-26-340292.md) | [4.5 d](/filings/0001193125-25-262699.md) | [(12.5) d](/filings/0001193125-26-100184.md) | [11.5](/filings/0001193125-26-214751.md) | [35.5 d](/filings/0001193125-26-340292.md) |

- Revenue. XBRL not reported.
- Gross margin (gross profit / revenue). XBRL not reported.
- Operating margin (operating income / revenue). XBRL not reported.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | not reported | not reported | not reported | not reported | not reported |
| Diluted EPS | $ per share | [3.43](/filings/0000950170-24-028081.md) | [3.51](/filings/0000950170-25-035585.md) | [0.50](/filings/0001193125-26-100184.md) | [4.00](/filings/0001193125-26-100184.md) | [1.23](/filings/0001193125-26-100184.md) |
| Free cash flow | $m | [97.6](/filings/0000950170-24-028081.md) | [70.6](/filings/0000950170-25-035585.md) | [61.0](/filings/0001193125-26-100184.md) | [65.4](/filings/0001193125-26-100184.md) | [38.1](/filings/0001193125-26-100184.md) |

- Revenue. XBRL not reported.
- Gross margin (gross profit / revenue). XBRL not reported.
- Operating margin (operating income / revenue). XBRL not reported.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/eqbk/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $74.9m | 1,529,825 |  | Added +151,536 |
| [Patriot Financial Partners GP II, L.P.](/funds/2061817.md) | 2026-06-30 | $49.8m | 1,017,214 |  | Reduced −177,149 |
| [FJ Capital Management LLC](/funds/1599170.md) | 2026-06-30 | $47.1m | 961,492 |  | Added +40,418 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $37.7m | 770,531 |  | Added +24,706 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $37.2m | 758,531 |  | Added +57,622 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $29.2m | 594,598 |  | Added +96,515 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $21.0m | 429,363 |  | Added +35,441 |
| [MANUFACTURERS LIFE INSURANCE COMPANY, THE](/funds/928047.md) | 2026-06-30 | $17.4m | 355,559 |  | Reduced −2,130 |
| [MENDON CAPITAL ADVISORS CORP](/funds/1177043.md) | 2026-06-30 | $15.9m | 324,569 |  | Reduced −57,481 |
| [Curi Capital, LLC](/funds/1332905.md) | 2026-06-30 | $14.9m | 305,000 |  | Reduced −45,000 |

## Recent filings

[All 981 filings](/companies/eqbk/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-14 | 20:20 ET | [8-K](/filings/0001193125-26-421701.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-421701 |
| 2026-10-05 | 01:50 ET | [8-K](/filings/0001193125-26-412873.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-412873 |
| 2026-09-14 | 20:45 ET | [8-K](/filings/0001193125-26-390696.md) | 8.01 Other events | 0001193125-26-390696 |
| 2026-09-03 | 11:46 ET | [8-K](/filings/0001193125-26-381051.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-381051 |
| 2026-08-07 | 20:18 ET | [10-Q](/filings/0001193125-26-340292.md) | Quarterly report, period 2026-06-30 | 0001193125-26-340292 |
| 2026-08-05 | 20:30 ET | [8-K](/filings/0001193125-26-335263.md) | 8.01 Other events | 0001193125-26-335263 |
| 2026-07-14 | 20:10 ET | [8-K](/filings/0001193125-26-303176.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-303176 |
| 2026-06-17 | 17:45 ET | [8-K](/filings/0001193125-26-273812.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-273812 |
| 2026-05-21 | 20:30 ET | [8-K](/filings/0001193125-26-234573.md) | 8.01 Other events | 0001193125-26-234573 |
| 2026-05-08 | 20:31 ET | [10-Q](/filings/0001193125-26-214751.md) | Quarterly report, period 2026-03-31 | 0001193125-26-214751 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001193125-26-096665.md), filed Mar 6, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 1227500
- Tickers: EQBK
- Exchange: NYSE
- SIC code: 6022 State Commercial Banks
- State of incorporation: KS
- Filer category: Accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:35 ET. No prices; not investment advice.